This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Investor Alert: Hagens Berman Advises Investors Of Pending Deadlines In Abiomed, Inc., Align Technology, Inc., And St. Jude Medical, Inc. Class Actions





SEATTLE, Jan. 7, 2013 /PRNewswire/ -- Hagens Berman today reminded investors of pending deadlines in securities class-action lawsuits filed on behalf of investors in three companies: Abiomed, Inc. (NASDAQ: ABMD), St. Jude Medical, Inc. (NYSE: STJ), and Align Technology, Inc. (NASDAQ: ALGN).

Investors who believe they may qualify for the position of lead plaintiff in the cases may contact Hagens Berman Partner Reed R. Kathrein by calling (510) 725-3000 or through the applicable email addresses below.

Abiomed, Inc.



A class-action lawsuit has been filed on behalf of investors who purchased Abiomed, Inc. stock between Aug. 5, 2011, and Oct. 31, 2012, both dates inclusive, alleging securities violations in connection with the marketing of its Impella 2.5 system.

Investors who believe they may qualify for the position of lead plaintiff in the case may contact Hagens Berman to discuss the investigation by emailing ABMD@hbsslaw.com. The deadline to move the court for lead plaintiff is Jan. 15, 2013.

More information is available at http://hb-securities.com/investigations/Abiomed.

Align Technology, Inc.



A class-action lawsuit has been filed on behalf of investors who purchased Align Technology, Inc. stock between April 23, 2012, and Oct. 17, 2012, both dates inclusive, alleging securities violations in connection with write downs associated with the company's acquisition of Cadent Holdings, Inc.

Investors who believe they may qualify for the position of lead plaintiff in the case may contact Hagens Berman to discuss the firm's investigation by emailing ALGN@hbsslaw.com. The deadline to move the court for lead plaintiff is Jan. 28, 2013.

More information is available at http://www.hb-securities.com/investigations/ALGN.

St. Jude Medical, Inc.



1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,911.65 -158.75 -0.88%
S&P 500 2,091.79 -22.70 -1.07%
NASDAQ 4,940.3570 -76.5720 -1.53%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs